Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Mr Matsubara of JPA Calls For Restriction on Long-term Prescriptions
September 12, 2005
- METI Will Not Ask for Hike in Tax Exemption Ceiling for R&D
September 12, 2005
- Korosho Presents Petition Asking for Preferential Taxation
September 12, 2005
- MEDICAL DEVICE NEWS IN BRIEF
September 12, 2005
- METI to Support Genome-based Drug Discovery: FY2006 Budget
September 12, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 12, 2005
- Korosho Asks for 3.5% Increase in General Accounts Budget
September 12, 2005
- NPA Recommends 0.36% Cut in Salary of National Gov't Employees
September 5, 2005
- Long-listed Drugs Should Be Reimbursed According to the Price of Their Generics: MOF
September 5, 2005
- OPINION
September 5, 2005
- Korosho Considers Reflecting Prices, Share of Generics in Prices of Long-listed Drugs
September 5, 2005
- Korosho, Monkasho to Draft New Plan to Promote Clinical Trials
September 5, 2005
- Japan Needs Review System That Meets Its Own Needs: Mr Asonuma
September 5, 2005
- SELF-MEDICATION NEWS IN BRIEF
September 5, 2005
- SURVEY 3 articles
September 5, 2005
- Tonic Drinks: Sales of New Quasi-drugs Outpace OTC Products
September 5, 2005
- Uncollected Medical Fees - Why Don't Patients Pay?
September 5, 2005
- HUMAN RESOURCE NEWS IN BRIEF
September 5, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 5, 2005
- 1st Qtr Business Results
September 5, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…